SOCAi

SOCAi builds computer vision AI innovations in health, wellness, and beauty, building a future where predictive insights & precise health solutions are accessible to everyone with just one scan.

We have active partnerships with the National Institute of Health, National Science Foundation, and the Department of Health and Human Services for our AI-digital health solutions. We also have an exclusive data partnerships with health organizations, including hospitals, to analyze medical data and have sales contracts that begin in the new year with Fortune 100 companies.

In the rapidly evolving healthcare landscape, traditional diagnostic methods often lack the precision and inclusivity needed for diverse skin types, leading to misdiagnoses and ineffective treatments. This gap in healthcare is particularly acute in dermatology, where visual cues are crucial for accurate diagnosis and treatment planning.

Harnessing the intelligence of millions of data points and developed by leading experts from Cornell, Harvard, and beyond, our AI-platform Layla provides precise, equitable dermatological insights. It is groundbreaking AI solution that revolutionizes skin, hair, & nail care diagnostics, offering tailored, effective treatment plans for all skin types. We seek to build an equitable world where predictive insights & precision health solutions are accessible to all with just one scan. Layla embodies cutting-edge technology & medical expertise, setting new standards in personalized healthcare.

We have both B2B and B2C business models for our AI products. For B2B we charge for API access as well as per user/analysis performed, while for B2C we charge users directly for access to our health analysis AI tools and treatment/product recommendation engines via our smartphone and web-accessible platform.